1.
Keshishian H, Burgess MW, Specht H, et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry. Nat Protoc. 2017;12(8):1683-1701. doi:10.1038/nprot.2017.054.
1.
Pevzner PA, Dančík V, Tang CL. Mutation-tolerant protein identification by mass spectrometry. J Comput Biol. 2000;7(6):777-87. doi:10.1089/10665270050514927.
1.
Lumpkin RJ, Gu H, Zhu Y, et al. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions. Nat Commun. 2017;8(1):1171. doi:10.1038/s41467-017-01271-3.
1.
Carr SA, Anderson L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?. Clin Chem. 2008;54(11):1749-52. doi:10.1373/clinchem.2008.114686.
1.
Udeshi ND, Mertins P, Svinkina T, Carr SA. Large-scale identification of ubiquitination sites by mass spectrometry. Nat Protoc. 2013;8(10):1950-60. doi:10.1038/nprot.2013.120.
1.
McHugh CA, Chen C-K, Chow A, et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521(7551):232-6. doi:10.1038/nature14443.
1.
He Y, Liu DR. Autonomous multistep organic synthesis in a single isothermal solution mediated by a DNA walker. Nat Nanotechnol. 2010;5(11):778-82. doi:10.1038/nnano.2010.190.
1.
Anderson L, Anderson NG, Pearson TW, et al. A human proteome detection and quantitation project. Mol Cell Proteomics. 2009;8(5):883-6. doi:10.1074/mcp.R800015-MCP200.
1.
Burgess MW, Keshishian H, Mani DR, Gillette MA, Carr SA. Simplified and efficient quantification of low-abundance proteins at very high multiplex via targeted mass spectrometry. Mol Cell Proteomics. 2014;13(4):1137-49. doi:10.1074/mcp.M113.034660.
1.
Cacciatore S, Loda M. Innovation in metabolomics to improve personalized healthcare. Ann N Y Acad Sci. 2015;1346(1):57-62. doi:10.1111/nyas.12775.